IMPACT OF DRUG REIMBURSEMENT MODALITIES ON TREATMENT ADHERENCE IN PATIENTS COVERED BY PRIVATE DRUG INSURANCE

被引:0
|
作者
Despres, F. [1 ]
Forget, A. [1 ]
Kettani, F. Z. [1 ]
Blais, L. [1 ]
机构
[1] Univ Montreal, Montreal, PQ, Canada
关键词
D O I
10.1016/j.jval.2014.03.108
中图分类号
F [经济];
学科分类号
02 ;
摘要
PHP44
引用
收藏
页码:A17 / A17
页数:1
相关论文
共 50 条
  • [31] DRUG ADHERENCE IN IBD PATIENTS
    Bucci, C.
    Cersosimo, G.
    Tammaro, S.
    Iovino, P.
    Ciacci, C.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E196 - E197
  • [32] Private health insurance coverage of drug use disorder treatment: 2005-2018
    Mojtabai, Ramin
    Mauro, Christine
    Wall, Melanie M.
    Barry, Colleen L.
    Olfson, Mark
    PLOS ONE, 2020, 15 (10):
  • [33] Orphan drug development: The impact of regulatory and reimbursement frameworks
    Huang, Yu-Jun
    Chao, Wan-Yu
    Wang, Chi-Chuan
    Chang, Lin-Chau
    DRUG DISCOVERY TODAY, 2022, 27 (06) : 1724 - 1732
  • [34] DRUG POLICY IN SLOVAKIA: IMPACT OF PRICING AND REIMBURSEMENT REFORMS
    Glatz, P.
    Ilavska, A.
    Hloska, A.
    Filko, M.
    VALUE IN HEALTH, 2010, 13 (03) : A95 - A95
  • [35] Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy
    Al-aqeel, Sinaa
    Al-sabhan, Jawza
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (01):
  • [36] MEASURING ADHERENCE TO DRUG TREATMENT IN MEXICAN PATIENTS: A SYSTEMATIC REVIEW
    Uc-Coyoc, R.
    Perez-Reynaud, A. G.
    Coello-Reyes, L. A.
    Ponce, Rodriguez-Diaz M. A.
    VALUE IN HEALTH, 2011, 14 (07) : A550 - A550
  • [37] Psychosocial factors and adherence to drug treatment in patients on chronic haemodialysis
    Huertas-Vieco, Maria P.
    Perez-Garcia, Rafael
    Albalate, Marta
    de Sequera, Patricia
    Ortega, Mayra
    Puerta, Marta
    Corchete, Elena
    Alcazar, Roberto
    NEFROLOGIA, 2014, 34 (06): : 737 - 742
  • [38] Adherence to drug treatment in hypertensive patients on the Family Health Program
    Ungari, Andrea Queiroz
    Dal Fabbro, Amaury Lelis
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 46 (04) : 811 - 818
  • [39] The impact of illicit drug use and substance abuse treatment on adherence to HAART
    Hicks, P. L.
    Mulvey, K. P.
    Chander, G.
    Fleishman, J. A.
    Josephs, J. S.
    Korthuis, P. T.
    Hellinger, J.
    Gaist, P.
    Gebo, K. A.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2007, 19 (09): : 1134 - 1140
  • [40] A survey of reimbursement practices of private health insurance companies for pharmaceuticals not covered under the Pharmaceutical Benefits Scheme 2008
    Lingaratnam, Senthil M.
    Kirsa, Sue W.
    Mellor, James D.
    Jackson, John
    Crellin, Wallace
    Fitzsimons, Michael
    Zalcberg, John R.
    AUSTRALIAN HEALTH REVIEW, 2011, 35 (02) : 204 - 210